Avadel Pharmaceuticals's total assets for Q1 2025 were $167.95M, an increase of 2.26% from the previous quarter. DE:AWK total liabilities were $93.88M for the fiscal quarter, a 3.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.